Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Pérez Luz, Sara ^a,b   Díaz Nido, Javier ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BLOOD CLOTTING FACTOR 8; DNA; DYSTROPHIN; EPSTEIN BARR VIRUS ANTIGEN 1; FRATAXIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INVASIN; LISTERIOLYSIN O; PARVOVIRUS VECTOR; PROTEIN ORIP; UNCLASSIFIED DRUG;

ARTIFICIAL CHROMOSOME; CENTROMERE; ENZYME ENGINEERING; EPISOME; FIBROBLAST; FRIEDREICH ATAXIA; GENE CONSTRUCT; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENE VECTOR; HEMOPHILIA A; HERPES SIMPLEX VIRUS 1; HUMAN; MINICHROMOSOME; MITOSIS; NONHUMAN; OXIDATIVE STRESS; REGULATORY SEQUENCE; REVIEW; SOMATIC CELL;

CHROMOSOMES, ARTIFICIAL, HUMAN; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FRIEDREICH ATAXIA; GENE EXPRESSION; GENE THERAPY; HEMOPHILIA A; HERPESVIRUS 4, HUMAN; HUMANS; IRON-BINDING PROTEINS; PLASMIDS;

EID: 77957848763     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/642804     Document Type: Review

References (196)

1. Dai Y., Schwarz E. M., Gu D., Zhang W.-W., Sarvetnick N., Verma I. M., Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression Proceedings of the National Academy of Sciences of the United States of America 1995 92 5 1401 1405
2. Lowenstein P. R., Mandel R. J., Xiong W.-D., Kroeger K., Castro M. G., Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions Current Gene Therapy 2007 7 5 347 360
3. Kochanek S., Clemens P. R., Mitani K., Chen H.-H., Chan S., Caskey C. T., A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and -galactosidase Proceedings of the National Academy of Sciences of the United States of America 1996 93 12 5731 5736
4. Kochanek S., Schiedner G., Volpers C., High-capacity 'gutless' adenoviral vectors Current Opinion in Molecular Therapeutics 2001 3 5 454 463
5. Lowenstein P. R., Thomas C. E., Umana P., Gerdes C. A., Verakis T., Boyer O., Tondeur S., Klatzmann D., Castro M. G., Lowenstein P. R., High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain Methods in Enzymology 2002 346 292 311
6. Pal G., Parolin C., Takeuchi Y., Pizzato M., Progress with retroviral gene vectors Reviews in Medical Virology 2000 10 3 185 202
7. Li Z., Dllmann J., Schiedlmeier B., Schmidt M., Von Kalle C., Meyer J., Forster M., Stocking C., Wahlers A., Frank O., Ostertag W., Khlcke K., Eckert H.-G., Fehse B., Baum C., Murine leukemia induced by retroviral gene marking Science 2002 296 5567 497
8. Thomas C. E., Ehrhardt A., Kay M. A., Progress and problems with the use of viral vectors for gene therapy Nature Reviews Genetics 2003 4 5 346 358
9. Check E., Regulators split on gene therapy as patient shows signs of cancer Nature 2002 419 6907 545 546
10. Naldini L., Blmer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D., In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272 5259 263 267
11. Reiser J., Harmison G., Kluepfel-Stahl S., Brady R. O., Karlsson S., Schubert M., Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles Proceedings of the National Academy of Sciences of the United States of America 1996 93 26 15266 15271
12. Pannell D., Osborne C. S., Yao S., Sukonnik T., Pasceri P., Karaiskakis A., Okano M., Li E., Lipshitz H. D., Ellis J., Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code EMBO Journal 2000 19 21 5884 5894
13. Jaenisch R., Transgenic animals Science 1988 240 4858 1468 1474
14. Pittman D. D., Alderman E. M., Tomkinson K. N., Wang J. H., Giles A. R., Kaufman R. J., Biochemical, immunological, and in vivo functional characterization of B- domain-deleted factor VIII Blood 1993 81 11 2925 2935
15. Huxley C., Exploring gene function: use of yeast artificial chromosome transgenesis Methods 1998 14 2 199 210
16. Sarsero J. P., Li L., Holloway T. P., Voullaire L., Gazeas S., Fowler K. J., Kirby D. M., Thorburn D. R., Galle A., Cheema S., Koenig M., Williamson R., Ioannou P. A., Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice Mammalian Genome 2004 15 5 370 382
17. Brem G., Besenfelder U., Aigner B., Muller M., Liebl I., Schutz G., Montoliu L., YAC transgenesis in farm animals: rescue of albinism in rabbits Molecular Reproduction and Development 1996 44 1 56 62
18. Giraldo P., Montoliu L., Size matters: use of YACs, BACs and PACs in transgenic animals Transgenic Research 2001 10 2 83 103
19. Pook M. A., Al-Mahdawi S., Carroll C. J., Cosse M., Puccio H., Lawrence L., Clark P., Lowrie M. B., Bradley J. L., Cooper J. M., Knig M., Chamberlain S., Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis Neurogenetics 2001 3 4 185 193
20. Moreira P. N., Pozueta J., Prez-Crespo M., Valdivieso F., Gutirrez-Adn A., Montoliu L., Improving the generation of genomic-type transgenic mice by ICSI Transgenic Research 2007 16 2 163 168
21. Manson A. L., Trezise A. E. O., MacVinish L. J., Kasschau K. D., Birchall N., Episkopou V., Vassaux G., Evans M. J., Colledge W. H., Cuthbert A. W., Huxley C., Complementation of null CF mice with a human CFTR YAC transgene EMBO Journal 1997 16 14 4238 4249
22. Hodgson J. G., Smith D. J., McCutcheon K., Koide H. B., Nishiyama K., Dinulos M. B., Stevens M. E., Bissada N., Nasir J., Kanazawa I., Disteche C. M., Rubin E. M., Hayden M. R., Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype Human Molecular Genetics 1996 5 12 1875 1885
23. Copeland N. G., Jenkins N. A., Court D. L., Recombineering: a powerful new tool for mouse functional genomics Nature Reviews Genetics 2001 2 10 769 779
24. Muyrers J. P. P., Zhang Y., Stewart A. F., Techniques: recombinogenic engineeringnew options for cloning and manipulating DNA Trends in Biochemical Sciences 2001 26 5 325 331
25. Narayanan K., Williamson R., Zhang Y., Stewart A. F., Ioannou P. A., Efficient and precise engineering of a 200 kb -globin human/bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system Gene Therapy 1999 6 3 442 447
26. Poser I., Sarov M., Hutchins J. R. A., Hrich J.-K., Toyoda Y., Pozniakovsky A., Weigl D., Nitzsche A., Hegemann B., Bird A. W., Pelletier L., Kittler R., Hua S., Naumann R., Augsburg M., Sykora M. M., Hofemeister H., Zhang Y., Nasmyth K., White K. P., Dietzel S., Mechtler K., Durbin R., Stewart A. F., Peters J.-M., Buchholz F., Hyman A. A., BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals Nature Methods 2008 5 5 409 415
27. Choo K. H. A., Centromere DNA dynamics: latent centromeres and neocentrome formation American Journal of Human Genetics 1997 61 6 1225 1233
28. Kurnit D. M., Maio J. J., Variable satellite DNA's in the African green monkey Cercopithecus aethiops Chromosoma 1974 45 4 387 400
29. Potter S. S., Jones R. S., Unusual domains of human alphoid satellite DNA with contiguous non-satellite sequences: sequence analysis of a junction region Nucleic Acids Research 1983 11 10 3137 3153
30. Rosenberg H., Singer M., Rosenberg M., Highly reiterated sequences of SIMIANSIMIANSIMIANSIMIANSIMIAN Science 1978 200 4340 394 402
31. Thayer R. E., Singer M. F., McCutchan T. F., Sequence relationships between single repeat units of highly reiterated African Green monkey DNA Nucleic Acids Research 1981 9 1 169 181
32. Willard H. F., Wayne J. S., Hierarchical order in chromosome-specific human alpha setellite DNA Trends in Genetics 1987 3 7 192 198
33. Larin Z., Fricker M. D., Tyler-Smith C., De novo formation of several features of a centromere following introduction of a Y alphoid YAC into mammalian cells Human Molecular Genetics 1994 3 5 689 695
34. Wevrick R., Willard H. F., Long-range organization of tandem arrays of satellite DNA at the centromeres of human chromosomes: high-frequency array-length polymorphism and meiotic stability Proceedings of the National Academy of Sciences of the United States of America 1989 86 23 9394 9398
35. Harrington J. J., Van Bokkelen G., Mays R. W., Gustashaw K., Willard H. F., Formation of de novo centromeres and construction of first-generation human artificial microchromosomes Nature Genetics 1997 15 4 345 355
36. Meja J. E., Alazami A., Willmott A., Marschall P., Levy E., Earnshaw W. C., Larin Z., Efficiency of de novo centromere formation in human artificial chromosomes Genomics 2002 79 3 297 304
37. Ohzeki J.-I., Nakano M., Okada T., Masumoto H., CENP-B box is required for de novo centromere chromatin assembly on human alphoid DNA Journal of Cell Biology 2002 159 5 765 775
38. Masumoto H., Ikeno M., Nakano M., Okazaki T., Grimes B., Cooke H., Suzuki N., Assay of centromere function using a human artificial chromosome Chromosoma 1998 107 6-7 406 416
39. Choo K. H. A., Centromerization Trends in Cell Biology 2000 10 5 182 188
40. du Sart D., Cancilla M. R., Earle E., Mao J.-I., Saffery R., Tainton K. M., Kalitsis P., Martyn J., Barry A. E., Andy Choo K. H., A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA Nature Genetics 1997 16 2 144 153
41. Depinet T. W., Zackowski J. L., Earnshaw W. C., Kaffe S., Sekhon G. S., Stallard R., Sullivan B. A., Vance G. H., Van Dyke D. L., Willard H. F., Zinn A. B., Schwartz S., Characterization of neo-centromeres in marker chromosomes lacking detectable alpha-satellite DNA Human Molecular Genetics 1997 6 8 1195 1204
42. Earnshaw W. C., Ratrie H. III, Stetten G., Visualization of centromere proteins CENP-B and CENP-C on a stable dicentric chromosome in cytological spreads Chromosoma 1989 98 1 1 12
43. Willard H. F., Neocentromeres and human artificial chromosomes: an unnatural act Proceedings of the National Academy of Sciences of the United States of America 2001 98 10 5374 5376
44. Yang J. W., Pendon C., Yang J., Haywood N., Chand A., Brown W. R. A., Human mini-chromosomes with minimal centromeres Human Molecular Genetics 2000 9 12 1891 1902
45. Lo A. W. I., Liao G. C.-C., Rocchi M., Choo K. H. A., Extreme reduction of chromosome-specific -satellite array is unusually common in human chromosome 21 Genome Research 1999 9 10 895 908
46. Ebersole T. A., Ross A., Clark E., McGill N., Schindelhauer D., Cooke H., Grimes B., Mammalian artificial chromosome formation from circular alphoid input DNA does not require telomere repeats Human Molecular Genetics 2000 9 11 1623 1631
47. Ikeno M., Grimes B., Okazaki T., Nakano M., Saitoh K., Hoshino H., McGill N. I., Cooke H., Masumoto H., Construction of YAC-based mammalian artificial chromosomes Nature Biotechnology 1998 16 5 431 439
48. Kotzamanis G., Cheung W., Abdulrazzak H., Perez-Luz S., Howe S., Cooke H., Huxley C., Construction of human artificial chromosome vectors by recombineering Gene 2005 351 29 38
49. Willard H. F., Chromosome manipulation: a systematic approach toward understanding human chromosome structure and function Proceedings of the National Academy of Sciences of the United States of America 1996 93 14 6847 6850
50. Burke D. T., Carle G. F., Olson M. V., Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors Science 1987 236 4803 806 812
51. Jakobovits A., Moore A. L., Green L. L., Vergara G. J., Maynard-Currie C. E., Austin H. A., Klapholz S., Germ-line transmission and expression of a human-derived yeast artificial chromosome Nature 1993 362 6417 255 258
52. Alazami A. M., Meja J. E., Monaco Z. L., Human artificial chromosomes containing chromosome 17 alphoid DNA maintain an active centromere in murine cells but are not stable Genomics 2004 83 5 844 851
53. Grimes B. R., Schindelhauer D., McGill N. I., Ross A., Ebersole T. A., Cooke H. J., Stable gene expression from a mammalian artificial chromosome EMBO Reports 2001 2 10 910 914
54. Meja J. E., Willmott A., Levy E., Earnshaw W. C., Larin Z., Functional complementation of a genetic deficiency with human artificial chromosomes American Journal of Human Genetics 2001 69 2 315 326
55. Meja J. E., Larin Z., The assembly of large BACs by in vivo recombination Genomics 2000 70 2 165 170
56. Kakeda M., Hiratsuka M., Nagata K., Kuroiwa Y., Kakitani M., Katoh M., Oshimura M., Tomizuka K., Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts Gene Therapy 2005 12 10 852 856 (Pubitemid 40753977)
57. Killary A. M., Fournier R. E. K., Microcell fusion Methods in Enzymology 1995 254 133 152
58. Hoshiya H., Kazuki Y., Abe S., Takiguchi M., Kajitani N., Watanabe Y., Yoshino T., Shirayoshi Y., Higaki K., Messina G., Cossu G., Oshimura M., A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene Molecular Therapy 2009 17 2 309 317
59. Kazuki Y., Hiratsuka M., Takiguchi M., Osaki M., Kajitani N., Hoshiya H., Hiramatsu K., Yoshino T., Kazuki K., Ishihara C., Takehara S., Higaki K., Nakagawa M., Takahashi K., Yamanaka S., Oshimura M., Complete genetic correction of iPS cells from Duchenne muscular dystrophy Molecular Therapy 2009 18 2 386 393
60. Rudd M. K., Mays R. W., Schwartz S., Willard H. F., Human artificial chromosomes with alpha satellite-based de novo centromeres show increased frequency of nondisjunction and anaphase lag Molecular and Cellular Biology 2003 23 21 7689 7697
61. Spence J. M., Mills W., Mann K., Huxley C., Farr C. J., Increased missegregation and chromosome loss with decreasing chromosome size in vertebrate cells Chromosoma 2006 115 1 60 74
62. Shen M. H., Yang J. W., Yang J., Pendon C., Brown W. R. A., The accuracy of segregation of human mini-chromosomes varies in different vertebrate cell lines, correlates with the extent of centromere formation and provides evidence for a trans-acting centromere maintenance activity Chromosoma 2000 109 8 524 535
63. Sclimenti C. R., Calos M. P., Epstein-Barr virus vectors for gene expression and transfer Current Opinion in Biotechnology 1998 9 5 476 479
64. Sugden B., Marsh K., Yates J., A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus Molecular and Cellular Biology 1985 5 2 410 413
65. Yates J., Warren N., Reisman D., Sugden B., A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells Proceedings of the National Academy of Sciences of the United States of America 1984 81 12 3806 3810
66. Yates J. L., Warren N., Sugden B., Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells Nature 1985 313 6005 812 815
67. Reisman D., Yates J., Sugden B., A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components Molecular and Cellular Biology 1985 5 8 1822 1832
68. Lupton S., Levine A. J., Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells Molecular and Cellular Biology 1985 5 10 2533 2542
69. Rawlins D. R., Milman G., Hayward S. D., Hayward G. S., Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region Cell 1985 42 3 859 868
70. Gahn T. A., Schildkraut C. L., The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication Cell 1989 58 3 527 535
71. Reisman D., Sugden B., trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1 Molecular and Cellular Biology 1986 6 11 3838 3846
72. Yates J. L., Guan N., Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells Journal of Virology 1991 65 1 483 488
73. Haase S. B., Calos M. P., Replication control of autonomously replicating human sequences Nucleic Acids Research 1991 19 18 5053 5058
74. Krysan P. J., Calos M. P., Epstein-Barr virus-based vectors that replicate in rodent cells Gene 1993 136 1-2 137 143
75. Nayyar V. K., Shire K., Frappier L., Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-bindingprotein 2 (EBP2) Journal of Cell Science 2009 122 23 4341 4350
76. Okayama H., Berg P., A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells Molecular and Cellular Biology 1983 3 2 280 289
77. Margolskee R. F., Kavathas P., Berg P., Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells Molecular and Cellular Biology 1988 8 7 2837 2847
78. Banerjee S., Livanos E., Vos J.-M. H., Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus Nature Medicine 1995 1 12 1303 1308
79. Lei D. C., Kunzelmann K., Koslowsky T., Yezzi M. J., Escobar L. C., Xu Z., Ellison A. R., Rommens J. M., Tsui L.-C., Tykocinski M., Gruenert D. C., Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells Gene Therapy 1996 3 5 427 436
80. Mcke S., Polack A., Pawlita M., Zehnpferunig D., Massoudi N., Bohlen H., Doerfler W., Bornkamm G., Diehl V., Wolf J., Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells Gene Therapy 1997 4 2 82 92
81. Young J. M., Cheadle C., Foulke J. S. Jr., Drohan W. N., Sarver N., Utilization of an Epstein-Barr virus replicon as a eukaryotic expression vector Gene 1988 62 2 171 185
82. Cachianes G., Ho C., Weber R. F., Williams S. R., Goeddel D. V., Leung D. W., Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins BioTechniques 1993 15 2 255 258
83. Simpson K., McGuigan A., Huxley C., Stable episomal maintenance of yeast artificial chromosomes in human cells Molecular and Cellular Biology 1996 16 9 5117 5126
84. Harris A., Young B. D., Griffin B. E., Random associated of Epstein-Barr virus genomes with host cell metaphase chromosome in Burkitt's lymphoma-derived cell lines Journal of Virology 1985 56 1 328 332
85. Huertas D., Howe S., McGuigan A., Huxley C., Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells Human Molecular Genetics 2000 9 4 617 629
86. Kaname T., Huxley C., Simple and efficient vectors for retrofitting BACs and PACs with mammalian neoR and EGFP marker genes Gene 2001 266 1-2 147 153
87. Magin-Lachmann C., Kotzamanis G., D'Aiuto L., Cooke H., Huxley C., Wagner E., In vitro and in vivo delivery of intact BAC DNAcomparison of different methods Journal of Gene Medicine 2004 6 2 195 209
88. Magin-Lachman C., Kotzamanis G., D'Aiuto L., Wagner E., Huxley C., Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1new vectors for in vitro and in vivo delivery BMC Biotechnology 2003 3, article no. 2
89. Courvalin P., Goussard S., Grillot-Courvalin C., Gene transfer from bacteria to mammalian cells Comptes Rendus de l'Academie des Sciences. Serie III 1995 318 12 1207 1212
90. Grillot-Courvalin C., Goussard S., Courvalin P., Wild-type intracellular bacteria deliver DNA into mammalian cells Cellular Microbiology 2002 4 3 177 186
91. Schaffner W., Direct transfer of cloned genes from bacteria to mammalian cells Proceedings of the National Academy of Sciences of the United States of America 1980 77 4 I 2163 2167
92. Grillot-Courvalin C., Goussard S., Courvalin P., Bacteria as gene delivery vectors for mammalian cells Current Opinion in Biotechnology 1999 10 5 477 481
93. Weiss S., Chakraborty T., Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers Current Opinion in Biotechnology 2001 12 5 467 472 (Pubitemid 32972171)
94. Xu D. Q., Zhang L., Kopecko D. J., Gao L., Shao Y., Guo B., Zhao L., Bacterial delivery of siRNAs: a new approach to solid tumor therapy Methods in Molecular Biology 2009 487 161 187
95. Chamekh M., Phalipon A., Quertainmont R., Salmon I., Sansonetti P., Allaoui A., Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus Journal of Immunology 2008 180 6 4292 4298
96. Stritzker J., Pilgrim S., Szalay A. A., Goebel W., Prodrug converting enzyme gene delivery by L. monocytogenes BMC Cancer 2008 8, article no. 94
97. Al-Mariri A., Tibor A., Lestrate P., Mertens P., De Bolle X., Letesson J.-J., Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen Infection and Immunity 2002 70 4 1915 1923
98. Sasaki T., Fujimori M., Hamaji Y., Hama Y., Ito K.-I., Amano J., Taniguchi S., Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats Cancer Science 2006 97 7 649 657
99. Michl P., Gress T. M., Bacteria and bacterial toxins as therapeutic agents for solid tumors Current Cancer Drug Targets 2004 4 8 689 702
100. Lee C.-H., Wu C.-L., Shiau A.-L., Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model Cancer Gene Therapy 2005 12 2 175 184
101. Ryan R. M., Green J., Williams P. J., Tazzyman S., Hunt S., Harmey J. H., Kehoe S. C., Lewis C. E., Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors Gene Therapy 2009 16 3 329 339
102. Li Z., Fallon J., Mandeli J., Wetmur J., Woo S. L. C., A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer Journal of the National Cancer Institute 2008 100 19 1389 1400
103. Theys J., Landuyt W., Nuyts S., Van Mellaert L., Van Oosterom A., Lambin P., Ann J., Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum Cancer Gene Therapy 2001 8 4 294 297
104. Ning J.-F., Zhu W., Xu J.-P., Zheng C.-Y., Meng X.-L., Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium Vaccine 2009 27 7 1127 1135
105. Abdul-Wahid A., Faubert G., Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle Vaccine 2007 25 50 8372 8383
106. Sandvig K., van Deurs B., Delivery into cells: lessons learned from plant and bacterial toxins Gene Therapy 2005 12 11 865 872
107. Grillot-Courvalin C., Goussard S., Huetz F., Ojcius D. M., Courvalin P., Functional gene transfer from intracellular bacteria to mammalian cells Nature Biotechnology 1998 16 9 862 866
108. Castagliuolo I., Beggiao E., Brun P., Barzon L., Goussard S., Manganelli R., Grillot-Courvalin C., Pal G., Engineered E. coli delivers therapeutic genes to the colonic mucosa Gene Therapy 2005 12 13 1070 1078
109. Isberg R. R., Voorhis D. L., Falkow S., Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells Cell 1987 50 5 769 778
110. Leong J. M., Fournier R. S., Isberg R. R., Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein EMBO Journal 1990 9 6 1979 1989
111. Leong J. M., Morrissey P. E., Isberg R. R., A 76-amino acid disulfide loop in the Yersinia pseudotuberculosis invasin protein is required for integrin receptor recognition Journal of Biological Chemistry 1993 268 27 20524 20532
112. Isberg R. R., Falkow S., A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12 Nature 1985 317 6034 262 264
113. Alouf J. E., Cholesterol-binding cytolytic protein toxins International Journal of Medical Microbiology 2000 290 4-5 351 356
114. Geoffroy C., Gaillard J.-L., Alouf J. E., Berche P., Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes Infection and Immunity 1987 55 7 1641 1646
115. Cossart P., Vicente M. F., Mengaud J., Baquero F., Perez-Diaz J. C., Berche P., Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation Infection and Immunity 1989 57 11 3629 3636
116. Laner A., Goussard S., Ramalho A. S., Schwarz T., Amaral M. D., Courvalin P., Schindelhauer D., Grillot-Courvalin C., Bacterial transfer of large functional genomic DNA into human cells Gene Therapy 2005 12 21 1559 1572
117. Narayanan K., Warburton P. E., DNA modification and functional delivery into human cells using Escherichia coli DH10B Nucleic Acids Research 2003 31 9, article no. e51
118. Prez-Luz S., Abdulrazzak H., Grillot-Courvalin C., Huxley C., Factor VIII mRNA expression from a BAC carrying the intact locus made by homologous recombination Genomics 2007 90 5 610 619
119. Poffenberger K. L., Tabares E., Roizman B., Characterization of a viable, noninverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S Proceedings of the National Academy of Sciences of the United States of America 1983 80 9 I 2690 2694
120. Oehmig A., Fraefel C., Breakefield X. O., Ackermann M., Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus Current Gene Therapy 2004 4 4 385 408
121. Wade-Martins R., Saeki Y., Chiocca E. A., Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells Molecular Therapy 2003 7 5 604 612
122. Mller L., Saydam O., Saeki Y., Heid I., Fraefel C., Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons Journal of Virological Methods 2005 123 1 65 72
123. Epstein A. L., Marconi P., Argnani R., Manservigi R., HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy Current Gene Therapy 2005 5 5 445 458
124. Johnson P. A., Miyanohara A., Levine F., Cahill T., Friedmann T., Cytotoxicity of a replication-defective mutant of herpes simplex virus type I Journal of Virology 1992 66 5 2952 2965
125. Saeki Y., Fraefel C., Ichikawa T., Breakefield X. O., Chiocca E. A., Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome Molecular Therapy 2001 3 4 591 601
126. Saeki Y., Ichikawa T., Saeki A., Chiocca E. A., Tobler K., Ackermann M., Breakefield X. O., Fraefel C., Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors Human Gene Therapy 1998 9 18 2787 2794
127. Agudo M., Luis Trejo J., Lim F., Avila J., Torres-Alemn I., Diaz-Nido J., Wandosell F., Highly efficient and specific gene transfer to purkinje cells in vivo using a herpes simplex virus I amplicon Human Gene Therapy 2002 13 5 665 674
128. Berges B. K., Wolfe J. H., Fraser N. W., Transduction of brain by herpes simplex virus vectors Molecular Therapy 2007 15 1 20 29
129. Fink D. J., DeLuca N. A., Goins W. F., Glorioso J. C., Gene transfer to neurons using herpes simplex virus-based vectors Annual Review of Neuroscience 1996 19 265 287
130. Frampton A. R. Jr., Goins W. F., Nakano K., Burton E. A., Glorioso J. C., HSV trafficking and development of gene therapy vectors with applications in the nervous system Gene Therapy 2005 12 11 891 901
131. Oehmig A., Fraefel C., Breakefield X. O., Update on herpesvirus amplicon vectors Molecular Therapy 2004 10 4 630 643
132. Jin B. K., Belloni M., Conti B., Federoff H. J., Starr R., Son J. H., Baker H., Joh T. H., Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector Human Gene Therapy 1996 7 16 2015 2024
133. Moralli D., Simpson K. M., Wade-Martins R., Monaco Z. L., A novel human artificial chromosome gene expression system using herpes simplex virus type 1 vectors EMBO Reports 2006 7 9 911 918
134. Borst E. M., Messerle M., Construction of a cytomegalovirus-based amplicon: a vector with a unique transfer capacity Human Gene Therapy 2003 14 10 959 970
135. Mannucci P. M., Tuddenham E. G. D., The hemophiliasfrom royal genes to gene therapy New England Journal of Medicine 2001 344 23 1773 1779
136. Chao H., Samulski R. J., Bellinger D. A., Monahan P. E., Nichols T. C., Walsh C. E., Persistent expression of canine factor IX in hemophilia B canines Gene Therapy 1999 6 10 1695 1704
137. Cherington V., Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion Human Gene Therapy 1998 9 10 1397 1407
138. Fang B., Eisensmith R. C., Wang H., Kay M. A., Cross R. E., Landen C. N., Gordon G., Bellinger D. A., Read M. S., Hu P. C., Brinkhous K. M., Woo S. L. C., Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression Human Gene Therapy 1995 6 8 1039 1044
139. Niemeyer G. P., Herzog R. W., Mount J., Arruda V. R., Tillson D. M., Hathcock J., Van Ginkel F. W., High K. A., Lothrop C. D. Jr., Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy Blood 2009 113 4 797 806
140. Kay M. A., High K., Gene therapy for the hemophilias Proceedings of the National Academy of Sciences of the United States of America 1999 96 18 9973 9975
141. Connelly S., Smith T. A. G., Dhir G., Gardner J. M., Mehaffey M. G., Zaret K. S., McClelland A., Kaleko M., In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice Human Gene Therapy 1995 6 2 185 193
142. Chuah M. K. L., Vandendriessche T., Morgan R. A., Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A Human Gene Therapy 1995 6 11 1363 1377
143. Eaton D. L., Hass P. E., Riddle L., Characterization of recombinant human factor VIII Journal of Biological Chemistry 1987 262 7 3285 3290
144. Toole J. J., A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity Proceedings of the National Academy of Sciences of the United States of America 1986 83 16 5939 5942
145. Eaton D. L., Wood W. I., Eaton D., Hass P. E., Hollingshead P., Wion K., Mather J., Lawn R. M., Vehar G. A., Gorman C., Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule Biochemistry 1986 25 26 8343 8347
146. Yang Y., Wilson J. M., Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo Journal of Immunology 1995 155 5 2564 2570
147. Connelly S., Gardner J. M., Lyons R. M., McClelland A., Kaleko M., Sustained expression of therapeutic levels of human factor VIII in mice Blood 1996 87 11 4671 4677 (Pubitemid 26162366)
148. Balagu C., Zhou J., Dai Y., Alemany R., Josephs S. F., Andreason G., Hariharan M., Sethi E., Prokopenko E., Jan H.-Y., Lou Y.-C., Hubert-Leslie D., Ruiz L., Zhang W.-W., Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector Blood 2000 95 3 820 828
149. Connelly S., Mount J., Mauser A., Gardner J. M., Kaleko M., McClelland A., Lothrop C. D. Jr., Complete short-term correction of canine hemophilia A by in vivo gene therapy Blood 1996 88 10 3846 3853
150. Andrews J. L., Shirley P. S., Iverson W. O., Sherer A. D., Markovits J. E., King L., Lyons R. M., Kaleko M., Connelly S., Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector Human Gene Therapy 2002 13 11 1331 1336 (Pubitemid 35034512)
151. Brown B. D., Shi C. X., Powell S., Hurlbut D., Graham F. L., Lillicrap D., Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A Blood 2004 103 3 804 810
152. Andrews J. L., Kadan M. J., Gorziglia M. I., Kaleko M., Connelly S., Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII Molecular Therapy 2001 3 3 329 336
153. Hoeben R. C., Van Der Jagt R. C. M., Schoute F., Van Tilburg N. H., Verbeet M. P., Briet E., Van Ormondt H., Van Der Eb A. J., Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer Journal of Biological Chemistry 1990 265 13 7318 7323
154. Israel D. I., Kaufman R. J., Retroviral-mediated transfer and amplification of a functional human factor VIII gene Blood 1990 75 5 1074 1080
155. Chuah M. K. L., Brems H., Vanslembrouck V., Collen D., VandenDriessche T., Bone marrow stromal cells as targets for gene therapy of hemophilia A Human Gene Therapy 1998 9 3 353 365
156. Fallaux F. J., Hoeben R. C., Cramer S. J., Van Den Wollenberg D. J. M., Brit E., Van Ormondt H., Van Der Eb A. J., The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate Molecular and Cellular Biology 1996 16 8 4264 4272
157. Hoeben R. C., Fallaux F. J., Cramer S. J., Van den Wollenberg D. J. M., Van Ormondt H., Briet E., Van der Eb A. J., Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region Blood 1995 85 9 2447 2454
158. Koeberl D. D., Halbert C. L., Krumm A., Miller A. D., Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation Human Gene Therapy 1995 6 4 469 479
159. Lynch C. M., Israel D. I., Kaufman R. J., Miller A. D., Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production Human Gene Therapy 1993 4 3 259 272
160. Byun J., Kim S.-H., Mook Kim J., Shin Yu S., Robbins P. D., Yim J., Kim S., Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy Gene Therapy 1996 3 9 780 788
161. Dwarki V. J., Belloni P., Nijjar T., Smith J., Couto L., Rabier M., Clift S., Berns A., Cohen L. K., Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice Proceedings of the National Academy of Sciences of the United States of America 1995 92 4 1023 1027
162. VandenDriessche T., Vanslembrouck V., Goovaerts I., Zwinnen H., Vanderhaeghen M.-L., Collen D., Chuah M. K. L., Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice Proceedings of the National Academy of Sciences of the United States of America 1999 96 18 10379 10384
163. Stein C. S., Kang Y., Sauter S. L., Townsend K., Staber P., Derksen T. A., Martins I., Qian J., Davidson B. L., McCray P. B. Jr., In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors Molecular Therapy 2001 3 6 850 856
164. Kootstra N. A., Matsumura R., Verma I. M., Efficient production of human FVIII in hemophilic mice using lentiviral vectors Molecular Therapy 2003 7 5 623 631
165. Chao H., Sun L., Bruce A., Xiao X., Walsh C. E., Expression of human factor VIII by splicing between dimerized AAV vectors Molecular Therapy 2002 5 6 716 722
166. Scallan C. D., Lillicrap D., Jiang H., Qian X., Patarroyo-White S. L., Parker A. E., Liu T., Vargas J., Nagy D., Powell S. K., Wright J. F., Turner P. V., Tinlin S. J., Webster S. E., McClelland A., Couto L. B., Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector Blood 2003 102 6 2031 2037
167. Youjin S., Jun Y., The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy Biotechnology Letters 2009 31 3 321 328
168. Roth D. A., Tawa N. E. Jr., O'Brien J. M., Treco D. A., Selden R. F., Nonviral transfer of the gene encoding coagulation factor viii in patients with severe hemophilia A New England Journal of Medicine 2001 344 23 1735 1742
169. Powell J. S., Ragni M. V., White G. C. II, Lusher J. M., Hillman-Wiseman C., Moon T. E., Cole V., Ramanathan-Girish S., Roehl H., Sajjadi N., Jolly D. J., Hurst D., Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion Blood 2003 102 6 2038 2045
170. Chuah M. K. L., Collen D., VandenDriassche T., Clinical gene transfer studies for hemophilia A Seminars in Thrombosis and Hemostasis 2004 30 2 249 256
171. Kotzamanis G., Huxley C., Recombining overlapping BACs into a single larger BAC BMC Biotechnology 2004 4, article no. 1
172. Campuzano V., Montermini L., Molt M. D., Pianese L., Cosse M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Caizares J., Koutnikova H., Bidichandani S. I., Gellera C., Brice A., Trouillas P., De Michele G., Filla A., De Frutos R., Palau F., Patel P. I., Di Donato S., Mandel J.-L., Cocozza S., Koenig M., Pandolfo M., Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion Science 1996 271 5254 1423 1427
173. Sakamoto N., Chastain P. D., Parniewski P., Ohshima K., Pandolfo M., Griffith J. D., Wells R. D., Sticky DNA: self-association properties of long GAA TTC repeats in R R Y triplex structures from Friedreich's ataxia Molecular Cell 1999 3 4 465 475
174. Patel P. I., Isaya G., Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency American Journal of Human Genetics 2001 69 1 15 24
175. Campuzano V., Montermini L., Lutz Y., Cova L., Hindelang C., Jiralerspong S., Trottier Y., Kish S. J., Faucheux B., Trouillas P., Authier F. J., Drr A., Mandel J.-L., Vescovi A., Pandolfo M., Koenig M., Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes Human Molecular Genetics 1997 6 11 1771 1780
176. Babcock M., De Silva D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L., Pandolfo M., Kaplan J., Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin Science 1997 276 5319 1709 1712
177. Adamec J., Rusnak F., Owen W. G., Naylor S., Benson L. M., Gacy A. M., Isaya G., Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia American Journal of Human Genetics 2000 67 3 549 562
178. Stehling O., Elssser H., Brckel B., Mhlenhoff U., Lill R., Iron-sulfur protein maturation in human cells: evidence for a function of frataxin Human Molecular Genetics 2004 13 23 3007 3015
179. Ristow M., Pfister M. F., Yee A. J., Schubert M., Michael L., Zhang C.-Y., Ueki K., Michael M. D. II, Lowell B. B., Kahn C. R., Frataxin activates mitochondrial energy conversion and oxidative phosphorylation Proceedings of the National Academy of Sciences of the United States of America 2000 97 22 12239 12243
180. Koutnikova H., Campuzano V., Foury F., Doll P., Cazzalini O., Koenig M., Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin Nature Genetics 1997 16 4 345 351
181. Cosse M., Puccio H., Gansmuller A., Koutnikova H., Dierich A., LeMeur M., Fischbeck K., Doll P., Knig M., Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation Human Molecular Genetics 2000 9 8 1219 1226
182. Puccio H., Simon D., Cosse M., Criqui-Filipe P., Tiziano F., Melki J., Hindelang C., Matyas R., Rustin P., Koenig M., Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits Nature Genetics 2001 27 2 181 186
183. Simon D., Seznec H., Gansmuller A., Carelle N., Weber P., Metzger D., Rustin P., Koenig M., Puccio H., Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia Journal of Neuroscience 2004 24 8 1987 1995
184. Miranda C. J., Santos M. M., Ohshima K., Smith J., Li L., Bunting M., Cosse M., Koenig M., Sequeiros J., Kaplan J., Pandolfo M., Frataxin knockin mouse FEBS Letters 2002 512 13 291 297
185. Al-Mahdawi S., Pinto R. M., Varshney D., Lawrence L., Lowrie M. B., Hughes S., Webster Z., Blake J., Cooper J. M., King R., Pook M. A., GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology Genomics 2006 88 5 580 590
186. Pandolfo M., Drug insight: antioxidant therapy in inherited ataxias Nature Clinical Practice Neurology 2008 4 2 86 96
187. Acquaviva F., Castaldo I., Filla A., Giacchetti M., Marmolino D., Monticelli A., Pinelli M., Sacc F., Cocozza S., Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression Cerebellum 2008 7 3 360 365
188. Boesch S., Sturm B., Hering S., Goldenberg H., Poewe W., Scheiber-Mojdehkar B., Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin Annals of Neurology 2007 62 5 521 524
189. Herman D., Jenssen K., Burnett R., Soragni E., Perlman S. L., Gottesfeld J. M., Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia Nature Chemical Biology 2006 2 10 551 558
190. Rai M., HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model PLoS One 2008 3 4, article no. e1958
191. Pianese L., Turano M., Lo Casale M. S., De Biase I., Giacchetti M., Monticelli A., Criscuolo C., Filla A., Cocozza S., Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers Journal of Neurology, Neurosurgery and Psychiatry 2004 75 7 1061 1063
192. Fleming J., Spinoulas A., Zheng M., Cunningham S. C., Ginn S. L., McQuilty R. C., Rowe P. B., Alexander I. E., Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors Human Gene Therapy 2005 16 8 947 956
193. Lim F., Palomo G. M., Mauritz C., Gimnez-Cassina A., Illana B., Wandosell F., Daz-Nido J., Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector Molecular Therapy 2007 15 6 1072 1078
194. Gomez-Sebastian S., Gimenez-Cassina A., Diaz-Nido J., Lim F., Wade-Martins R., Infectious delivery and expression of a 135kb human FRDA genomic DNA locus complements friedreich's ataxia deficiency in human cells Molecular Therapy 2007 15 2 248 254
195. Wade-Martins R., Smith E. R., Tyminski E., Chiocca E. A., Saeki Y., An infectious transfer and expression system for genomic DNA loci in human and mouse cells Nature Biotechnology 2001 19 11 1067 1070
196. Glorioso J. C., Fink D. J., Herpes vector-mediated gene transfer in the treatment of chronic pain Molecular Therapy 2009 17 1 13 18